To evaluate the effectiveness of a 24-week course of treatment with abatacept (orencia) versus usual care to prevent patients from developing more active joints.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Laura Cannon
Pediatrics - Children's Research Institute
Clinical or Medical
Interventional
Bones, Joints, Muscles
Child and Teen Health
Immune System/Infections
19-1389
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
